J Booij Selected Research

J Booij Research Topics

Disease

8	Parkinson Disease (Parkinson's Disease) 01/2014 - 01/2001
6	Parkinsonian Disorders (Parkinsonism) 02/2012 - 05/2000
5	Tremor (Tremors) 10/2017 - 05/2000
4	Schizophrenia (Dementia Praecox) 01/2010 - 06/2000
3	Dementia (Dementias) 01/2020 - 03/2008
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2009
2	Disease Progression 06/2016 - 12/2005
2	Multiple System Atrophy 01/2014 - 03/2001
2	Myoclonic dystonia 01/2012 - 02/2009
2	Essential Tremor (Essential Tremors) 05/2000 - 05/2000
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 05/2022
1	REM Sleep Behavior Disorder 01/2021
1	Intellectual Disability (Idiocy) 12/2017
1	Phenylketonurias (Phenylketonuria) 12/2017
1	Torticollis (Wryneck) 10/2017
1	Insulin Resistance 11/2016
1	Overweight 11/2016
1	Hearing Loss (Hearing Impairment) 06/2015
1	Psychotic Disorders (Schizoaffective Disorder) 04/2015
1	Obesity 05/2013
1	22q11 Deletion Syndrome 10/2010
1	Delayed Graft Function 09/2010
1	Depressive Disorder (Melancholia) 01/2010
1	Anxiety Disorders (Anxiety Disorder) 01/2010
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2010
1	Major Depressive Disorder (Major Depressive Disorders) 01/2010
1	Cognitive Dysfunction 06/2009
1	Dystonia (Limb Dystonia) 02/2009
1	Wounds and Injuries (Trauma) 04/2008
1	Body Weight (Weight, Body) 03/2008
1	Lewy Body Disease (Lewy Body Dementia) 03/2008
1	Mental Disorders (Mental Disorder) 11/2007
1	Hypokinesia (Bradykinesia) 11/2001
1	Tardive Dyskinesia 04/2001
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2001
1	Stroke (Strokes) 06/2000
1	Memory Disorders (Memory Loss) 02/2000

Drug/Important Bio-Agent (IBA)

13	Dopamine (Intropin)FDA LinkGeneric 12/2017 - 06/2000
10	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020 - 05/2000
8	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 01/2001
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2020 - 05/2008
4	Serotonin (5 Hydroxytryptamine)IBA 01/2010 - 02/2000
3	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 05/2008 - 11/2001
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2012 - 03/2001
2	Methylphenidate (Ritalin)FDA LinkGeneric 03/2008 - 03/2001
2	Olanzapine (Zyprexa)FDA Link 06/2001 - 06/2000
2	Risperidone (Risperdal Consta)FDA LinkGeneric 06/2001 - 06/2000
2	Amphetamine (Amfetamine)FDA LinkGeneric 03/2001 - 01/2001
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 06/2000 - 02/2000
1	fluorocholineIBA 05/2022
1	alpha-SynucleinIBA 01/2021
1	SynucleinsIBA 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 12/2017
1	Tyrosine (L-Tyrosine)FDA Link 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 11/2016
1	Insulin (Novolin)FDA Link 11/2016
1	Bromocriptine (Parlodel)FDA LinkGeneric 11/2016
1	Biomarkers (Surrogate Marker)IBA 06/2016
1	CarbohydratesIBA 05/2013
1	Dihydroxyphenylalanine (Dopa)IBA 02/2012
1	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 10/2010
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2010
1	Amyloid (Amyloid Fibrils)IBA 06/2009
1	propylene (propene)IBA 04/2008
1	AminesIBA 04/2008
1	OximesIBA 04/2008
1	Donepezil (Aricept)FDA LinkGeneric 03/2008
1	Rivastigmine (Exelon)FDA LinkGeneric 03/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2007
1	Levodopa (L Dopa)FDA LinkGeneric 11/2005
1	Neuroprotective AgentsIBA 03/2003
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2001
1	Antipsychotic Agents (Antipsychotics)IBA 04/2001
1	Illicit Drugs (Recreational Drugs)IBA 06/2000
1	Serotonin ReceptorsIBA 02/2000

Therapy/Procedure

1	Deep Brain Stimulation 01/2012
1	Nephrectomy 09/2010
1	Kidney Transplantation 09/2010